The scientific instruments maker saw its shares rise 1% following the announcement. For the fourth quarter of 2024, Bruker posted adjusted earnings per share of $0.76, exceeding the analyst ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Organic revenue growth - Bruker Scientific Instruments (BSI): 4.5% versus 3.3% estimated by two analysts on average. Organic revenue growth - Bruker Energy & Supercon Technologies (BEST): -2.8% ...

Q4 2024 reported revenues increased 14.6% year-over-year to $979.6 million, supported by acquisitions and 4.5% organic growth in the Bruker Scientific Instruments (BSI) segment. Non-GAAP diluted ...

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

M&T Bank Corp lifted its stake in Bruker Co. (NASDAQ:BRKR – Free Report) by 303.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,870 shares of the medical ...

Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.

Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.

Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: ...

Fourth quarter 2024 Bruker Scientific Instruments (BSI) revenues of $911.3 million increased 16.3% year-over- year, with organic revenue growth of 4.5%. Fourth quarter 2024 Bruker Energy ...